首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
mental and behavioural disorder due to use of amphetamine相关文献:
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Faraone SV.
Neurosci Biobehav Rev. 2018 Apr;87:255-270. doi: 10.1016/j.neubiorev.2018.02.001. Epub 2018 Feb 8.
PMID:29428394
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant H.
CMAJ. 2001 Oct 2;165(7):917-28.
PMID:11599334
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.
N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.
PMID:30893533
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Castells X, Blanco-Silvente L, Cunill R.
Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3.
PMID:30091808
Safety of Stimulants Across Patient Populations: A Meta-Analysis.
Oliva HNP, Prudente TP, Mayerson TF, Mignosa MM, Oliva IO, Potenza MN, Jegede OO, Angarita GA.
JAMA Netw Open. 2025 May 1;8(5):e259492. doi: 10.1001/jamanetworkopen.2025.9492.
PMID:40343695
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D, Leach MJ, Perez Algorta G.
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
PMID:37058600
Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database.
Wu L, Zhao D, Lan Y, Jin L, Yang L.
BMC Pharmacol Toxicol. 2025 Feb 20;26(1):38. doi: 10.1186/s40360-025-00868-5.
PMID:39980035
Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes.
Taipale H, Bergström J, Gèmes K, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M.
JAMA Netw Open. 2024 Mar 4;7(3):e242859. doi: 10.1001/jamanetworkopen.2024.2859.
PMID:38506810
Use Motives of Patients with Amphetamine-Type Stimulants Use Disorder and Attention-Deficit/Hyperactivity Disorder.
Thurn D, Riedner A, Wolstein J.
Eur Addict Res. 2020;26(4-5):254-262. doi: 10.1159/000508871. Epub 2020 Jun 19.
PMID:32564027
Binge Eating Disorder.
Guerdjikova AI, Mori N, Casuto LS, McElroy SL.
Psychiatr Clin North Am. 2017 Jun;40(2):255-266. doi: 10.1016/j.psc.2017.01.003. Epub 2017 Mar 6.
PMID:28477651
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3